EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Exploring the gap between sensor‐detected ( SDH ) and person‐reported hypoglycaemia ( PRH ): The voice of people living with diabetes

Monika Cigler iD, Omaima El-Hakouni iD, Renald Mecani iD, François Pouwer iD, Evertine J Abbink iD, Michaela Moser iD, Bastiaan E de Galan iD, Eric Renard iD, Mark Evans iD, Julie Maria Bøggild Brøsen iD, Ulrik Pedersen-Bjergaard iD, Rory J McCrimmon iD und 10 weitere

Diabetic Medicine · 2026

DOI: 10.1111/dme.70301 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Monika Cigler und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hypoglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: IHI, European Commission, European Federation of Pharmaceutical Industries and Associations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims In people with insulin‐treated diabetes experiencing hypoglycaemia, the multicentre Hypo‐METRICS study found that 60% of sensor‐detected hypoglycaemic episodes (SDH) were asymptomatic, and over 40% of person‐reported hypoglycaemia (PRH) occurred at glucose levels ≥70 mg/dL (3.9 mmol/L). This subanalysis explored participants' experiences of these episodes to identify possible clinical implications.

Methods

Fifty‐eight Austrian participants received a 15‐item questionnaire on their experience of asymptomatic hypoglycaemia and symptoms at glucose levels ≥70 mg/dL (3.9 mmol/L).

Results

The response rate was 86% ( n = 50). Among all participants, 56% ( n = 28) reported experiencing hypoglycaemic symptoms at glucose levels ≥70 mg/dL (3.9 mmol/L) “sometimes” or “often.” They attributed this to a combination of a threshold shift due to chronic hyperglycaemia, rapid glucose decline and fear of hypoglycaemia. 68% of all SDH < 70 mg/dL and 59% of those below the clinically critical level of 54 mg/dL were asymptomatic.

Conclusion

These results demonstrate that SDH and PRH each capture different, yet equally important, dimensions of the hypoglycaemia experience. Relying on only one source of information inevitably provides an incomplete picture. By integrating the patient's voice, diabetes professionals can provide appropriate support and tailor continuous glucose monitoring (CGM) alarm settings and treatment plans to truly meet individual needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HypoglycemiaHypoglycemic AgentsAdultAgedFemaleHumansMaleMiddle AgedAustriaBlood GlucoseBlood Glucose Self-MonitoringContinuous Glucose MonitoringInsulinSelf ReportSurveys and Questionnaires

Stichwörter der Autor:innen

continuous blood glucose monitoringdiabetespatient experiencetype 1 diabetestype 2 diabetes

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • Steno Diabetes Center Odense (SDCO), Odense, Denmark.
  • Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
  • Department of Internal Medicine of Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Department for Applied Computer Sciences/Business Informatics, FH Joanneum, Graz, Austria.

ORCID-Profile: Monika Cigler, Omaima El-Hakouni, Renald Mecani, François Pouwer, Evertine J Abbink, Michaela Moser, Bastiaan E de Galan, Eric Renard, Mark Evans, Julie Maria Bøggild Brøsen, Ulrik Pedersen-Bjergaard, Rory J McCrimmon, Simon Heller, Petra M Baumann, Uffe Søholm, Silvia Basta, Patrick Divilly, Natalie Zaremba, Stephanie A Amiel, Pratik Choudhary, Julia K Mader

Förderung

  • IHI
  • European Commission
  • European Federation of Pharmaceutical Industries and Associations

Zitieren

APA

Cigler, M., El-Hakouni, O., Mecani, R., Pouwer, F., Abbink, E. J., Moser, M., de Galan, B. E., Renard, E., Evans, M., Brøsen, J. M. B., Pedersen-Bjergaard, U., McCrimmon, R. J., Heller, S., Baumann, P. M., Søholm, U., Basta, S., Divilly, P., Zaremba, N., Amiel, S. A., …, & Hypo‐RESOLVE consortium (2026). Exploring the gap between sensor‐detected ( SDH ) and person‐reported hypoglycaemia ( PRH ): The voice of people living with diabetes. Diabetic Medicine. https://doi.org/10.1111/dme.70301

Vancouver

Cigler M, El-Hakouni O, Mecani R, Pouwer F, Abbink EJ, Moser M, et al. Exploring the gap between sensor‐detected ( SDH ) and person‐reported hypoglycaemia ( PRH ): The voice of people living with diabetes. Diabetic Medicine. 2026. doi:10.1111/dme.70301

BibTeX
@article{Cigler2026,
  author = {Cigler, Monika and El-Hakouni, Omaima and Mecani, Renald and Pouwer, François and Abbink, Evertine J and Moser, Michaela and de Galan, Bastiaan E and Renard, Eric and Evans, Mark and Brøsen, Julie Maria Bøggild and Pedersen-Bjergaard, Ulrik and McCrimmon, Rory J and Heller, Simon and Baumann, Petra M and Søholm, Uffe and Basta, Silvia and Divilly, Patrick and Zaremba, Natalie and Amiel, Stephanie A and Choudhary, Pratik and Mader, Julia K and Hypo‐RESOLVE consortium, Hypo‐RESOLVE consortium},
  title = {Exploring the gap between sensor‐detected ( SDH ) and person‐reported hypoglycaemia ( PRH ): The voice of people living with diabetes},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70301}
}
Kostenlos starten →